Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, yet no 2 cases look alike, says Philip Mease, MD, director of rheumatology and research, Providence Swedish Medical Center, ...

Please provide your email address to receive an email when new articles are posted on . Compared with methotrexate, systemic therapies for psoriasis either reduced or slightly increased cardiovascular ...

The National Psoriasis Foundation issued a new position statement that clarifies the definition of psoriasis disease severity ...

Patients with psoriasis often have comorbidities that are linked to the systemic inflammation of psoriasis and its treatment, according to study findings published in The Journal of Dermatology. The ...

Older adults with severe or refractory psoriatic disease face a unique challenge: Balancing the need for effective systemic treatment with the increased risk for serious infections. A cohort study ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In patients with plaque psoriasis, studies have shown that ...

A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity ...

Like other inflammatory conditions, psoriasis often comes with concurrent systemic comorbidities, and physicians should be aware of symptoms that suggest associated conditions. Comorbidities include ...

Topical treatments, such as ointments, creams, lotions, and sprays, are often the first-line treatment for people with psoriasis. As psoriasis progresses or becomes more severe, though, topical ...